July 22 (Reuters) - Suda Pharmaceuticals Ltd SUD.AX :
* EUROPEAN PATENT OFFICE HAS INFORMED SUDA THAT IT INTENDS TO GRANT CO'S ANAGRELIDE PATENT
* PLANS TO ADVANCE INTO PHASE 1 CANCER CLINICAL TRIALS UNDERWAY
July 22 (Reuters) - Suda Pharmaceuticals Ltd SUD.AX :
* EUROPEAN PATENT OFFICE HAS INFORMED SUDA THAT IT INTENDS TO GRANT CO'S ANAGRELIDE PATENT
* PLANS TO ADVANCE INTO PHASE 1 CANCER CLINICAL TRIALS UNDERWAY